Clinical Trial

Evaluation of Circadian OS Technology on Melatonin Suppression

Completed
View on ClinicalTrials.gov →
Summary
Primary Objective: Evaluate how the Circadian OS iPad-based light intervention suppresses melatonin. This small pilot study is designed to validate the Circadian OS technology by testing physiological response using melatonin suppression. The study aims to evaluate how the Circadian OS iPad-based light intervention influences sleepiness as measured objectively via suppression of melatonin and subjectively via the Karolinska Sleepiness scale.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-24; most recent amendment 2026-01-13.
Status change: Active, Not Recruiting → Completed 2026-01-13
Status change: Recruiting → Active, Not Recruiting 2025-09-15
Trial Details
NCT Number NCT07095270
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Circadian Disruption
Enrollment 10 participants
Start Date 2025-07-07
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-15